Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer

IMPORTANCE: A critical decision in the management of metastatic castration-resistant prostate cancer (mCRPC) is when to administer an androgen receptor signaling (ARS) inhibitor or a taxane. OBJECTIVE: To determine if pretherapy nuclear androgen-receptor splice variant 7 (AR-V7) protein expression a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:JAMA Oncol
Autores principales: Scher, Howard I., Lu, David, Schreiber, Nicole A., Louw, Jessica, Graf, Ryon P., Vargas, Hebert A., Johnson, Ann, Jendrisak, Adam, Bambury, Richard, Danila, Daniel, McLaughlin, Brigit, Wahl, Justin, Greene, Stephanie B., Heller, Glenn, Marrinucci, Dena, Fleisher, Martin, Dittamore, Ryan
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5206761/
https://ncbi.nlm.nih.gov/pubmed/27262168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2016.1828
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares